CA2333895A1 - Snurportin i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof - Google Patents

Snurportin i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof Download PDF

Info

Publication number
CA2333895A1
CA2333895A1 CA002333895A CA2333895A CA2333895A1 CA 2333895 A1 CA2333895 A1 CA 2333895A1 CA 002333895 A CA002333895 A CA 002333895A CA 2333895 A CA2333895 A CA 2333895A CA 2333895 A1 CA2333895 A1 CA 2333895A1
Authority
CA
Canada
Prior art keywords
polypeptide
nucleic acid
cap
snurportin
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002333895A
Other languages
English (en)
French (fr)
Inventor
Christoph Huls
Claus Simandi
Reinhard Luhrmann
Jochen Huber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Research and Technologies GmbH and Co KG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2333895A1 publication Critical patent/CA2333895A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
CA002333895A 1998-07-14 1999-07-07 Snurportin i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof Abandoned CA2333895A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19831382A DE19831382A1 (de) 1998-07-14 1998-07-14 Humanes m¶3¶G-cap-spezifisches Kernimportrezeptorprotein mit einer neuen Domänenstruktur, dessen Herstellung und Verwendung
DE19831382.9 1998-07-14
PCT/EP1999/004750 WO2000004144A1 (de) 1998-07-14 1999-07-07 Snurportin 1, humanes m3g-cap-spezifisches kernimportrezeptorprotein mit einer neuen domänenstruktur, dessen herstellung und verwendung

Publications (1)

Publication Number Publication Date
CA2333895A1 true CA2333895A1 (en) 2000-01-27

Family

ID=7873911

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002333895A Abandoned CA2333895A1 (en) 1998-07-14 1999-07-07 Snurportin i human m3g-cap specific nucleus import receptor protein with new domain structure, the production and use thereof

Country Status (6)

Country Link
EP (1) EP1097201A1 (de)
JP (1) JP2002520052A (de)
AU (1) AU751571B2 (de)
CA (1) CA2333895A1 (de)
DE (1) DE19831382A1 (de)
WO (1) WO2000004144A1 (de)

Also Published As

Publication number Publication date
WO2000004144A1 (de) 2000-01-27
JP2002520052A (ja) 2002-07-09
DE19831382A1 (de) 2000-02-03
AU4908599A (en) 2000-02-07
AU751571B2 (en) 2002-08-22
EP1097201A1 (de) 2001-05-09

Similar Documents

Publication Publication Date Title
AU707598B2 (en) Cell death protein
US6277979B1 (en) KIAA0551 polynucleotides and polypeptides use
US6376661B1 (en) Human RNase H and compositions and uses thereof
US20040167066A1 (en) Cleavage and polyadenylation complex of precursor mrna
JP2003156489A (ja) 痛みに関連する分子の同定及び使用
CA2303760A1 (en) A potential effector for the grb7 family of signalling proteins
US6492168B1 (en) Methyltransferase gene and enzyme
JP2001506850A (ja) 脂肪細胞特異的分化関連タンパク質
AU702844B2 (en) Interleukin-1 receptor-associated protein kinase and assays
AU751571B2 (en) Snurpotine 1 human M3G-CAP specific nucleus import receptor protein with new domain structure, the production and use thereof
JP2003210183A (ja) ヒトＩκＢ−β
AU733462B2 (en) CYP7 promoter-binding factors
JP2002501378A (ja) ヒト腫瘍関連Ｋａｚａｌインヒビタ
JPH10304883A (ja) 新規化合物
AU777034B2 (en) Human RNase H and compositions and uses therof
JPH11243972A (ja) アミノペプチダーゼファミリーのメンバー、ｍｅｔｐｒｏ ０２
US6919427B1 (en) Polypeptide-rna binding protein 33 and polynucleotide encoding said polypeptide
AU727305B2 (en) A potential effector for the GRB7 family of signalling proteins
WO1996022367A1 (en) Nucleic acid encoding a stress-responsive subunit of human rna polymerase ii
US20030144496A1 (en) Human RNase H and compositions and uses thereof
JP2001518794A (ja) ヒトｇｔｐ結合タンパク質
JP2000226400A (ja) アポトーシス制御能を有する蛋白質、その遺伝子及びそれらの用途
WO2005085285A2 (en) Nuclear hormone receptors
JPH11155583A (ja) Ａｓｐ５
WO1995015386A1 (fr) Nouvelle tyrosine-kinase receptrice

Legal Events

Date Code Title Description
FZDE Dead